Clinical Trial Update: A Study of DS-2248 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update for DS-2248 in advanced solid tumors; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma
• Solid Tumors

Drugs mentioned

• DS-2248

Snippet

Sponsor: Daiichi Sankyo | Conditions: Solid Tumors, Non-small Cell Lung Carcinoma | Phase 1 | Status: TERMINATED | Results posted: 2020-07-10